The objective of this study is to collect the hemostatic effectiveness and device safety data of "HANBIO" Gauze in subjects have acute wound result from gynecology surgery.

Inclusion Criteria:

• Female between 20 and 70 years of age.
• Subject scheduled for a non-emergent, gynecological surgery.
• Subject has an identified bleeding site/area intraoperatively.
• Subject is willing to comply with all aspects of the study and have signed informed consent form.

Exclusion Criteria:

• Pregnant or lactating female.
• The wound is chronic wound that not healed within 8 weeks, e.g. ulcers.
• The wound is caused by radiation or burns.
• Subject is sensitive or allergic to collagen.
• Subject is sensitive or allergic to polyester (PET).
• Subject has medical history of coagulation disorder or disease (e.g., hemophilia, thrombocytopenia).
• Subject receives anticoagulants or antiplatelets.
• Subject plans to receive other hemostatic gauze/dressing/agent/medical device as primary hemostasis.
• Subject has participated in another clinical trial within the past 30 days.
• Subjects with any pre-operative or intra-operative findings that may preclude conduct of the study procedure or unable to evaluate the outcomes.